Translational RAAS Interest Group

The Translational RAAS Interest Group (TRIG) is a nonprofit organization dedicated to advancing knowledge and understanding of the Renin-Angiotensin-Aldosterone System (RAAS). TRIG brings together medical professionals and scientists from both veterinary and human healthcare fields to foster innovative research and collaboration.

Mission Statement

The mission of TRIG is to serve as a leader in RAAS research, facilitating projects that improve the understanding and modulation of the RAAS to enhance the lives of individuals and companion animals suffering from cardiovascular and kidney diseases.

Activities and Objectives

• Collaboration and Research: TRIG encourages collaboration among its members, providing a platform for sharing resources, initiating research projects, and engaging in clinical trials.
• Symposium and Forums: The organization plans to host symposia like the RAAS, cardiorenal, and diuretic resistance crosstalk symposium to promote discussion and knowledge exchange.
• Grant Awards: TRIG issues requests for proposals (RFPs) to award seed grants for studies focusing on various aspects of RAAS, aiming to address clinically relevant questions and improve patient outcomes.

Leadership and Membership

TRIG is led by an executive board with roles such as president, secretary, and treasurer. Membership is open to medical professionals and scientists interested in RAAS-related research. The organization is structured to include various coordinators and a scientific advisory panel, which plays a crucial role in reviewing grant proposals and guiding research directions.

Funding and Financial Status

TRIG operates as a nonprofit organization, seeking funding from sponsors like Ceva Santé Animale. The organization's financial management involves awarding grants based on the recommendations of its scientific advisory panel.